A major advance in cancer study is arising with the use of mini-antibodies to reactivate damaged p53. This crucial tumor suppressor protein is frequently lost in various forms of malignancies, resulting uncontrolled https://setbookmarks.com/story21971227/nanobodies-reactivate-tumor-suppressor-p53-a-potential-hope-for-cancer-therapy